However, the EML4-ALK fusion gene is not specific to NSCLC, which has also been observed in many other tumors, such as IMT [34], pediatric rhabdomyosarcoma [35], high-grade pediatric glioma [36], ovarian cancer [37], and cholangiocarcinoma [38]. This evidence concerns the gene ALK and cholangiocarcinoma.